赛诺医疗科学技术股份有限公司关于公司冠脉产品获得国内医疗器械注册证的公告

Core Viewpoint - Sino Medical has received the Medical Device Registration Certificate for its drug-eluting stent system, marking a significant milestone in its product development and commercialization efforts [2][4]. Group 1: Medical Device Registration Details - The product is a drug-eluting stent system composed of a drug-coated stent and a rapid exchange balloon catheter delivery system [2]. - The stent is made from L605 cobalt-chromium alloy and features a non-degradable bottom coating and a biodegradable drug coating containing rapamycin and PLGA [2][3]. - The drug dosage density is 1.20 μg/mm², with a drug loading range of 59 μg to 324 μg [2]. Group 2: Product Specifications and Usage - The stent is designed for use in blood vessels with diameters ranging from 2.25 mm to 5.00 mm and is intended to alleviate symptoms of ischemic heart disease [2][3]. - The product has a shelf life of 18 months and is sterilized using electron beam technology for single-use [2]. Group 3: Impact on the Company - The approval of the drug-eluting stent system enhances the company's product portfolio and is expected to meet diverse market demands, potentially boosting sales and core competitiveness [4]. - The product is classified as a Class III medical device, requiring further production licensing before it can be manufactured and sold [4].

SINOMED-赛诺医疗科学技术股份有限公司关于公司冠脉产品获得国内医疗器械注册证的公告 - Reportify